When was Latch founded?

Latch was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Latch located?

Latch is headquartered in San Francisco, United States.

How many employees does Latch have?

As of Sep 30, 2026, the latest employee count at Latch is 79.

Is Latch a funded company?

Latch is a funded company, having raised a total of $33M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 04, 2021.

When was the latest funding round of Latch?

Latch's latest funding was a $***** Series A round on Jun 02, 2022, with participation from 6 investors. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.88B in funding in 2026 to date.

Where does Latch rank among its competitors?

Latch ranks 4th amongst 602 active competitors, of which 82 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was OutSee, which secured $3.36M in Jan, 2026.

Who are the top competitors of Latch?

Latch's top competitors include Benchling, Helix and Sophia Genetics. Among them, OutSee secured the most recent funding round in January, 2026.

Latch - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of a web-based platform for genomic bioinformatics. The company offers a biocomputing platform that enables biologists to analyze CRISPR data, and creates open-source machine learning and cloud infrastructure for the next generation of therapeutic discovery.

Website: latch.bio
Social
Email ID: *****@latch.bio

Key Metrics

Founded Year

2021

Location

San Francisco, United States

Stage

Series A

Total Funding

$33M in 2 rounds

Latest Funding Round

Series A, Jun 02, 2022, $*****

Investors

Lux Capital & 8 more

Ranked

4^th among 602 active competitors

Employee Count

79 as on Sep 30, 2026

Similar Companies

Benchling & 759 more

View Latch's full profile

Latch has raised a total funding of $33M over 2 rounds. Its first funding round was on Oct 04, 2021. Its latest funding round was a Series A round on Jun 02, 2022 for $*****. 6 investors participated in its latest round. Latch has 8 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Latch:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 02, 2022	7792685	Series A	2757637	6876935	6907739	8636241
Oct 04, 2021	3346595	Seed	9286501	8220264	Lux Capital	Fifty Years & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Latch's funding rounds and investors

The founders of Latch are Alfredo Andere, Kyle Giffin and Kenny Workman.

Here are the details of Latch's key team members:

Alfredo Andere: Co-Founder of Latch. They are also an angel investor in 2 startups.
Contact Info: 1 email address
Kyle Giffin: Co-Founder of Latch.
Kenny Workman: Co-Founder and CTO of Latch.

View details of Latch's Founder profiles and Board Members

Latch's employee count trend

Latch has 79 employees as of Sep 26. Here is Latch's employee count trend over the years:

Uncover Latch's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Latch include Benchling, Helix and Sophia Genetics. Here is the list of Top 10 competitors of Latch, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Benchling 2012, San Francisco (United States), Series F	Developer of cloud software for laboratory research and development data	$412M	Altimeter Capital, Benchmark & 29 others	73/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 13 others	73/100
3rd	Sophia Genetics 2011, Rolle (Switzerland), Public	Provider of artificial intelligence software for analyzing complex medical data	$249M	Generation Investment Management, Endeavour Vision ... & 25 others	62/100
4th	Latch 2021, San Francisco (United States), Series A	Provider of a web-based platform for genomic bioinformatics	$33M	Hummingbird Ventures, Caffeinated Capital ... & 7 others	60/100
5th	54gene 2019, Lagos (Nigeria), Deadpooled	Provider of gene biobanking database and services for research purposes	$45M	Better Ventures, Fifty Years & 20 others	54/100
6th	OutSee United Kingdom, Seed	Developer of an artificial intelligence engine for predictive genomics	$5.79M	Ahren, Panacea Venture & 2 others	54/100
7th	Zetta Genomics 2018, Worcester (United Kingdom), Seed	Provider of genomic data analysis software for clinical labs & research organizations	$10.4M	Nina Capital, APEX Ventures & 12 others	54/100
8th	BostonGene 2015, Waltham (United States), Series B	Developer of cloud-based information and analytics platform to treat cancer	$200M	NEC, Japan Industrial Partners & 1 others	53/100
9th	Codetta 2021, Morrisville (United States), Series A	Online platform for analyzing omics clinical data	$27.3M	Anzu Partners, VC23 & 2 others	50/100
10th	Congenica 2013, Cambridge (United Kingdom), Acquired	Developer of software for clinical genomic interpretation and variant analysis	$81.9M	IDO Investments, Xeraya Capital & 41 others	52/100